To
make these careful determinations on each of 5,000 applications annually,
the UMHS relies on 60 IRBMED board members, assisted by 18 staff members,
and the advice of two attorneys from the Office of the General Counsel.
The IRBMED boards are co-chaired by Dr. Vernon Sondak, Professor of
Surgery, and Dr. Robert Cody, Professor of Internal Medicine-Cardiology.
Each of the four boards meets for 3-4 hours bi-weekly to review and
either approve, disapprove, or require modifications in proposals involving
human research subjects.
The IRBMED
Office is located on the 4th floor (street level) of the Kresge I building,
and is under the direction of Patricia Ward, Director of Clinical Research
Services for the Office of Research and Graduate Studies. The staff
is comprised of five Medical Research Specialists, six Application Specialists,
two Coordinators, two secretaries, a file clerk, and an office manager.
The Medical Research Specialists have solid biomedical research backgrounds,
and are charged with providing regulatory assistance to both investigators
and IRBMED members. The Application Specialists assist the Medical Research
Specialists, and are responsible for maintaining electronic and paper
records in good order and regulatory compliance. The Coordinators are
responsible for educational activities, compliance issues, and other
special initiatives. One of the IRBMED secretaries serves as Receptionist
and "Document Intake Specialist;" while the other serves as Board Secretary
and is responsible for all activities and records related to the board
members, rosters, and meetings. The IRBMED File Clerk maintains the
enormous IRBMED central file system and delivers review materials by
the box to the IRBMED members on a daily basis. Last but not least,
the IRBMED Office Manager keeps it all going by handling personnel,
financial, and facility/equipment matters.
Affymetrix
Microarray Core Opens
In an effort to broaden investigator access to Affymetrix GeneChip technologies,
the Medical School, with support from the Executive Vice President for
Medical Affairs and the Vice President for Research, has opened a centralized
Affymetrix Microarray Core. The Affymetrix Microarray Core will initially
provide very focused services on a recharge basis. These services include
GeneChip processing, GeneChip scanning and data analysis assistance.
For answers to questions about fees or access to this core facility,
contact either Dennis Martin (647-2751 or dennism@umich.edu)
or Robert Thompson (615-3117 or mutant@umich.edu).
Presentation
Provides Intro to New HIPAA Legislation
Edward Goldman, UMHS General Counsel, will speak at a presentation that
provides a thorough introduction of HIPAA issues to be considered in
research. A question and answer session will follow the presentation.
The presentation will take place on November 13, 2002 from 12 to 2 PM
in room M3330 Medical Science Bldg. I. Contact: June Insco, Education
and Compliance Coordinator, IRBMED at insco@umich.edu
or 7-1969. The new HIPAA legislation becomes effective in April 2003.
This new law will impact aspects of research including access to patient
records when planning a study or recruiting subjects. Informed consent
documents may need to be altered to accommodate the law.
Medical
School Faculty Elected to National Academies
Congratulations to Michael Savageau, Ph.D., Professor and Chair of Microbiology/Immunology
and Thomas Schwenk, M.D., Professor and Chair of Family Medicine. They
have been elected as members to the Institute of Medicine of the National
Academies in Washington DC.
Richard
Keep Appointed Crosby-Kahn Collegiate Professor
The Regents of the U-M have appointed Richard F. Keep, Ph.D., as Crosby-Kahn
Collegiate Professor of Neurosurgery and Neuroanatomy. This collegiate
professorship was established at the UMMS in 1993 to recognize the significant
contributions made by Drs. Elizabeth C. Crosby and Edgar A. Kahn, and
their efforts in promoting the importance of involving neuroscientists
in understanding and managing complex clinical problems. Congratulations
Dr. Keep.
Funding Opportunities
U-M
Biomedical Technology Development Fund
Deadline: November 15, 2002
The Biomedical Technology Development Fund (BTDF), created by the Dean
of the Medical School, is intended to provide funding for research and
development projects or programs that have already demonstrated technology
transfer promise through basic research, but are not ready for commercial
translation. This fund is specifically designed to support activities
that would increase or maximize the potential for these projects to
be transferred out of the University. Grants up to $50,000 will be considered.
Average Grants are expected to be between $20,000 and 25,000. Applications
may be funded for up to two years pending successful review of an annual
progress report. All awardees are required to submit a final report
upon completion of their project. For further information and application
form, visit the website or call Technology Transfer and Corporate Research
at 734-763-6363.
U-M
Sarah Goddard Power Award
Deadline: November 22, 2002
U-M's Academic Women’s Caucus requests nominations for the Sarah Goddard
Power Award. The Award is given to honor members of the University community
who have made significant contributions to the development of the status
of women at the U-M in addition to demonstrating exceptional leadership,
notable scholarship or significant professional accomplishments. Nominations
may be submitted online through the Human Resources and Affirmative
Action website or by requesting a form from the Office of Equity and
Diversity Services, 4005 Wolverine Tower, 3003 South State Street, (734)
763-0235 or TTY (734) 647-1388. Four hard copies of the nominee’s CV
and other supporting documents must be sent directly to Sally Grace
at the address listed above.
U-M
Organogenesis Postdoctoral Fellowship Competition
Deadline: December 1, 2002
A postdoctoral fellowship has been established through NIH support provided
by the Center for Organogenesis Training Grant. The goal of this NRSA
Fellowship Award is to provide two years of support to a postdoctoral
fellow (PhD and/or MD degree) who wishes to undertake a research project
in the field of Organogenesis. The research project must cross interdisciplinary
lines and must fit within the goals of the Center for Organogenesis.
Applicants must be US Citizens or permanent residents. Contacts: Deborah
Gumucio (dgumucio@umich.edu)
or Rebecca Pintar (rpintar@umich.edu).
Pfizer/SWHR
Scholars Grants for Faculty Development in Women's Health
Internal Deadline: November 11, 2002
The purpose of this initiative is to provide support to promising physician-scientists
whose research will explore biological mechanisms of diseases in women
in the areas of cardiovascular disease, mental health, and reproductive
physiology. Grants of $65,000 per year for 3 years are provided to the
sponsoring medical school on behalf of the Scholar. Applicants must
have a M.D. or D.O. with 12 years or fewer of professional experience
in his/her specialty area as of July 2003 and have a full-time faculty
appointment below the level of associate professor. Pfizer will accept
up to 3 applications from each institution (1 from each designated area),
but will confer only 1 award per institution in a given competition.
Deadline for submission of proposals to Pfizer is December 10, 2002.
For consideration as the institutional nominee, submit the following
by November 11, 2002: a 1-2 page research summary, a CV, and a nominating
letter from the department chair. Submit all internal applications to
the Office of Research and Graduate Studies, 4107 Med Sci I, Box 0624.
Contact: Denise Swayze, 763-4086 or dswayze@umich.edu.
Damon
Runyon Clinical Investigator Award
Internal
Deadline: January 14, 2003
The Clinical Investigator Award program is specifically intended to
provide outstanding young physicians with the resources and training
structure essential to becoming independent clinical investigators in
the area of cancer research. Applicants must have a M.D. or M.D./Ph.D.
degree from an accredited institution and be board-eligible in a cancer
or cancer related specialty (e.g., oncology, pathology, radiation therapy,
surgery, and hematology). Applicants may apply during the final year
of their subspecialty training or within the first four-years of their
assistant professorship appointment. The award will provide financial
support for the investigator ($100,000 per year for 5 years), a senior
mentor (15,000-30,000 per year for 4 years) and the costs of research
(75,000 per year). The Foundation will retire up to $100,000 of any
medical school debt still owed by the awardee. The University of Michigan
may nominate one individual. Deadline for submission of an application
to Damon Runyon is March 3, 2003. For consideration as the institutional
nominee, submit the following by January 14, 2003: a 1-2 page research
summary, a CV, and a nominating letter from the department chair. Submit
all internal applications to the Office of Research and Graduate Studies,
4107 Med Sci I, Box 0624. Contact: Denise Swayze, 763-4086 or dswayze@umich.edu.
Howard
Hughes Medical Institute Predoctoral Fellowships in Biological Sciences
Deadline: November 12, 2002
The Howard Hughes Medical Institute will award at least 80 five-year
fellowships for full-time study toward a Ph.D. or a Sc.D. degree in
the biological sciences. The National Research Council administers the
competition. The Award is an annual stipend of $21,000, an annual fellow's
allowance of $2,500, and an annual institutional allowance of $13,500.
The fellowships are for students who have completed less than one year
of graduate study toward a M.S., a Ph.D., or a Sc.D. degree in the biological
sciences. Students who hold or are pursuing medical or dental degrees
(M.D., D.O., D.V.M., and D.D.S.) may be eligible to apply for fellowship
support for study toward a Ph.D. or a Sc.D. The program is open to both
U.S. citizens and foreign citizens. Students with U.S. citizenship may
take the fellowship abroad. Non-U.S. citizens must study in the United
States. The application deadline is November 12 2002. Applicants must
apply via the Web.
Robert
Wood Johnson Health Policy Fellowships
Deadline: November 15, 2002
The Robert Wood Johnson (RWJ) Fellowship Program provides outstanding
mid-career health professionals an opportunity to gain an understanding
of the health policy process and to contribute to the formulation of
new policies and programs. The program will help them develop in their
careers as leaders in academic health centers and in health policy.
Grants are $155,000 for three years. See the RWJ website for complete
details, application and qualification information.
Bristol-Myers
Squibb Awards Cancer Research
Deadline: November 15, 2002
Cardiovascular Research, Deadline: December 16, 2002 Neuroscience Research,
Deadline: January 23, 2003 Bristol-Myers Squibb Company presents annual
awards to scientists who make outstanding contributions to progress
in cancer, cardiovascular, and neuroscience research. Candidates for
the awards are to be nominated by individuals affiliated with medical
schools, hospitals and neuroscience research centers. The awards are
$50,000 each.
American
Society for Clinical Investigation (ASCI)
Deadline: November 22, 2002
The ASCI is accepting nominations for 2003 membership and the 2003 ASCI
Award from September 23 through November 22, 2002. The ASCI is an honor
society of physician-scientists, those who translate findings in the
laboratory to the advancement of clinical practice. Membership The Society
maintains an Institutional Representatives program, in which one member
facilitates communication among all ASCI members at an institution.
The Society maintains a database of academic centers and corporations
ranked by the number of affiliated members. 2003 ASCI Award The purpose
of the $20,000 Award is to recognize an outstanding member of the ASCI.
Current ASCI members who will be 55 or younger in 2003, and who are
not currently serving on the ASCI Council, are eligible for the award.
Bayer
Hemophilia Awards Program
Deadline: November 29, 2002 (Letter of Intent)
Bayer Biological Products a division of the Bayer Corporation, has established
a $2.75 million annual grant initiative to fund hemophilia research
and education programs around the world. Available to any professional
in the worldwide hemophilia community who wishes to apply, the program
will provide grants supporting basic and clinical research and education
in hemophilia to early career investigators, fellows in training, and
other hemophilia care professionals. The program, which focuses on projects
involving inherited, bleeding disorders and hemostasis, will make awards
in four categories: the Bayer Hemophilia Special Projects Award, the
Early Career Investigator Award, the Clinical Scholarship Award, and
the Bayer Hemophilia Caregivers Education Award. Applications for the
Bayer Hemophilia Awards will be processed solely via the Internet.
Howard
Hughes Medical Institute/NIH Research Scholars Program
Deadline: January 10, 2003
The appointment for this program is for nine months to one year of full-time
research. Research is conducted at the National Institutes of Health.
The Cloister, a residential facility for scholars, is available on the
NIH campus. The project is selected after a round of laboratory visits.
The program includes an annual salary of $17,800, plus benefits. There
is no special research allowance. Costs are covered by the scholar's
laboratory. Students may apply for funding to support an additional
year of research or up to two years of medical studies.
Albany
Medical Center Prize in Medicine and Biomedical Research
Deadline January 15, 2003
The Albany Medical Center is seeking nominations for their 2003 Prize
in Medicine and Biomedical Research (the largest prize in medicine in
the United States). The purpose of the prize is to promote and recognize
exceptional and sustained contributions to improving health care and
advancing innovative biomedical research. The $500,000 Prize will be
presented to the recipient at an award ceremony in Albany, New York.
Any physician, scientist or group, whose work leads to notable advances
in health care and scientific research with demonstrable benefits, is
eligible for this prize. Nominations will be accepted through January
15, 2003.
Sandler
Program for Asthma Research (SPAR)
Deadline: February 14, 2003
The intent of this award is to develop important new pathways of investigation
in basic research regarding asthma. Of particular interest are applications
from outstanding investigators outside the field of asthma, such as
in basic immunology, virology, pathology, genetics, cell biology, signaling,
molecular pharmacology, etc. Investigators from within the field are
also eligible for awards provided that the proposed work represents
a major departure from their current and past research. SPAR is looking
for truly novel ideas with breakthrough potential, and accepts that
this approach may entail substantial risk and very limited preliminary
data. Awards are $250,000 per year for three years for senior investigators
and $125,000 per year for three years for junior investigators.
Ellison
Medical Foundation Senior Scholar Awards in Aging
Deadline: February 28, 2003 (Letter of intent)
The Senior Scholar program is designed to support biomedical research
on aging, including basic biology, epidemiology, and clinical investigation
by established investigators, working at institutions in the U.S., in
basic biological and clinical sciences relevant to understanding aging
processes and age-related diseases and disabilities. The award is intended
to provide significant support to established investigators in order
to allow the development of new, creative research programs by investigators
who may not currently be conducting aging research or who may wish to
develop new research programs in aging. The award will be for $150,000
per year, direct cost, with indirect costs added to that for up to four
years.
Seminars
Center
for Organogenesis Seminars
The Center for Organogenesis announces two November seminars.
November
7, 2002 at 3:30 PM at 5915 Buhl
Henry M. Kronenberg, M.D., Chief, Endocrine Unit, Massachusetts General
Hospital, Boston, Massachusetts, will speak on: "How PTHrP Regulates
Bone Growth".
November
21, 2002 at 3:30 PM at 5915 Buhl Mats Ljungman, Ph.D., Associate Professor,
Department of Radiation Oncology, UM Comprehensive Cancer Center, will
speak on: "Transcription - Guarding the Genome by Sensing DNA Damage".
Contact: Rebecca Pintar rpintar@umich.edu.
International Perspective to CAMComplementary Med
The
CAM Research Center hosts a seminar on Monday, November 11th from
12-1:00 PM in the MCHC Auditorium. The speaker will be Moshe Frenkel,
M.D., Co-Director of the Complementary and Traditional Medicine Unit
at the Department of Family Medicine, Rappaport Faculty of Medicine
Technion-Israel, Institute of Technology, Haifa, Israel. He teaches
pharmacists, family practice residents and medical staff members about
complementary medicine; as well as advising the Israeli Ministry of
Education on curriculum content. Contact camrc@umich.edu
or visit their website.
New
Two-Day Bioinformatics Conference
The
Department of Pathology is sponsoring a new two-day conference November
12-13 starting at 8:00 AM at the Towsley Center focusing on pathology
bioinformatics. A dozen faculty members will present their current research
in genomics and proteomics, with strong emphasis on the application
of information technology to research in disease processes. All UM faculty
and students are eligible for complementary registration. There is a
fee for conference catering and the syllabus. Contact the Towsley registrar
at 763-1400 to pre register.
